Review Article
Underarm cosmetics and breast cancer
P. D. Darbre,
Corresponding Author
P. D. Darbre
Division of Cell and Molecular Biology, School of Animal and Microbial Sciences, University of Reading, PO Box 228, Whiteknights, Reading RG6 6AJ, UK
Division of Cell and Molecular Biology, School of Animal and Microbial Sciences, University of Reading, PO Box 228, Whiteknights, Reading RG6 6AJ, UK.Search for more papers by this author
P. D. Darbre,
Corresponding Author
P. D. Darbre
Division of Cell and Molecular Biology, School of Animal and Microbial Sciences, University of Reading, PO Box 228, Whiteknights, Reading RG6 6AJ, UK
Division of Cell and Molecular Biology, School of Animal and Microbial Sciences, University of Reading, PO Box 228, Whiteknights, Reading RG6 6AJ, UK.Search for more papers by this authorAbstract
Although risk factors are known to include the loss of function of the susceptibility genes BRCA1/BRCA2 and lifetime exposure to oestrogen, the main causative agents in breast cancer remain unaccounted for. It has been suggested recently that underarm cosmetics might be a cause of breast cancer, because these cosmetics contain a variety of chemicals that are applied frequently to an area directly adjacent to the breast. The strongest supporting evidence comes from unexplained clinical observations showing a disproportionately high incidence of breast cancer in the upper outer quadrant of the breast, just the local area to which these cosmetics are applied. A biological basis for breast carcinogenesis could result from the ability of the various constituent chemicals to bind to DNA and to promote growth of the damaged cells. Multidisciplinary research is now needed to study the effect of long-term use of the constituent chemicals of underarm cosmetics, because if there proves to be any link between these cosmetics and breast cancer then there might be options for the prevention of breast cancer. Copyright © 2003 John Wiley & Sons, Ltd.
REFERENCES
- Ahmad R, Naoui M, Neault JF, Diamantoglou S, Tajmir-Riahi HA. 1996. An FITR specroscopic study of calf thymus DNA complexation with Al(III) and Ga(III) cations. J. Biomol. Struct. Dyn. 13: 795– 802.
- Anane R, Bonini M, Grafeille JM, Creppy EE. 1995. Bioaccumulation of water soluble aluminium chloride in the hippocampus after transdermal uptake in mice. Arch. Toxicol. 69: 568– 571.
- Anane R, Bonini M, Creppy EE. 1997. Transplacental passage of aluminium from pregnant mice to fetus organs after maternal transcutaneous exposure. Hum. Exp. Toxicol. 16: 501– 504.
- Anderson TJ. 1991. Genesis and source of breast cancer. Br. Med. Bull. 47: 305– 318.
- Azzena A, Zen T, Ferrara A, Brunetti V, Vasile C, Marchetti M. 1994. Risk factors for breast cancer. Eur. J. Gynaecol. Oncol. 15: 386– 392.
- Baxter PM, Reed JV. 1983. The evaluation of underarm deodorants. Int. J. Cosmet. Sci. 5: 85– 96.
- Blair RM, Fang H, Branham WS, et al. 2000. The estrogen receptor relative binding affinities of 188 natural and xenochemicals: structural diversity of ligands. Toxicol. Sci. 54: 138– 153.
- Busk T, Clemmensen J. 1947. The frequencies of left- and right-sided breast cancer. Br. J. Cancer 1: 345.
- Byford JR, Shaw LE, Drew MGB, Pope GS, Sauer MJ, Darbre PD. 2002. Oestrogenic activity of parabens in MCF7 human breast cancer cells. J. Steroid Biochem. Mol. Biol. 80: 49– 60.
- DalPozzo A, Pastori N. 1996. Percutaneous absorption of parabens from cosmetic formulations. Int. J. Cosmet. Sci. 18: 57– 66.
- Darbre PD. 1998. Environmental contaminants in milk: the problem of organochlorine xenobiotics. Biochem. Soc. Trans. 26: 106– 112.
- Darbre PD. 2001a. Underarm cosmetics are a cause of breast cancer. Eur. J. Cancer Prevent. 10: 389– 393.
- Darbre PD. 2001b. Oestrogens in the environment. Educ. Chem. 39: 124– 128.
- Darbre PD, Byford JR, Shaw LE, Horton RA, Pope GS, Sauer MJ. 2002. Oestrogenic activity of isobutylparaben in vitro and in vivo. J. Appl. Toxicol. 22: 219– 226.
- Darbre PD, Byford JR, Shaw LE, Hall S, Coldham NG, Pope GS, Sauer MJ. 2003. Oestrogenic activity of benzylparaben. J. Appl. Toxicol. 23: 43– 51.
- Dixon JM, McDonald C, Elton RA, Miller WR. 1999. Risk of breast cancer in women with palpable breast cysts: a prospective study. Lancet 353: 1742– 1745.
- Dobson S, van Esch GJ. 1993. Polychlorinated Biphenyls and Terphenyls ( 2nd edn), Environmental Health Criteria 140. World Health Organization: Geneva.
- Donegan WL, Spratt JS. 1967. Cancer of the second breast. In Cancer of the Breast, JS Spratt, Donegan WL (eds). WB Saunders: Philadelphia; 179.
- Easton D, Ford D, Peto J. 1993. Inherited susceptibility to breast cancer. Cancer Surv. 18: 95– 113.
- Elder RL. 1984. Final report on the safety assessment of methylparaben, ethylparaben, propylparaben and butylparaben. J. Am. Coll. Toxicol. 3: 147– 209.
10.3109/10915818409021274 Google Scholar
- Exley C. 1998. Does antiperspirant use increase the risk of aluminium-related disease, including Alzheimer's disease? Mol. Med. Today March: 107– 109.
- Exley C. 2001. Aluminium and Alzheimer's Disease: the Science that Describes the Link. Elsevier: Amsterdam.
- Flarend R, Bin T, Elmore D, Hem SL. 2001. A preliminary study of the dermal absorption of aluminium from antipersirants using aluminium-26. Food Chem. Toxicol. 39: 163– 168.
- Flick EW. 1989. Cosmetic and Toiletry Formulations. Noyes Publications: Park Ridge, NJ.
- Garfinkel L, Craig L, Seidman H. 1959. An appraisal of left and right breast cancer. J. Natl. Cancer Inst. 23: 617.
- Haagensen CD. 1971. Diseases of the Breast ( 2nd edn). WB Saunders: Philadelphia.
- Habs H, Simon B, Thiedemann KU, Howe O. 1997. Aluminium, Environ Health Criteria 194. World Health Organization: Geneva, 1– 207.
- Harnett WL. 1948. A statistical report on 2529 cases of cancer of the breast. Br. J. Cancer 2: 212.
- Hilakivi-Clarke, L. 2000. Estrogens, BRCA1, and breast cancer. Cancer Res. 69: 4993– 5001.
- Hossani A, Larsen JJ, Larsen JC. 2000. Lack of oestrogenic effects of food preservatives (parabens) in uterotropic assays. Food Chem. Toxicol. 38: 319– 323.
- Hussain MA, Sawkat A, Tyagi SP, Reza H. 1994. Incidence of cancer breast at Aligarh. J. Indian Med. Assoc. 92: 296– 297.
- Jaiyesimi IA, Buzdar AU, Sahin AA, Ross MA. 1992. Carcinoma of the male breast. Ann. Intern. Med. 117: 771– 777.
- Jepson AS, Fentiman IS. 1998. Male breast cancer. Int J Clin Pract 52: 571– 576.
- Jobling S, Reynolds T, White R, Parker MG, Sumpter JP. 1995. A variety of environmentally persistent chemicals, including some phthalate plasticizers, are weakly estrogenic. Environ. Health Perspect. 103: 582– 587.
- Karlik SJ, Eichhorn GL, Lewis PN, Crapper DR. 1980. Interaction of aluminium species with deoxyribonucleic acid. Biochemistry 19: 5991– 5998.
- Laden K, Felger CB. 1988. Antiperspirants and deodorants. Cosmetic Science and Technology Series, vol. 7. Marcel Dekker: New York.
- Lane-Claypon JE. 1926. A further report on cancer of the breast with special reference to its associated antecedent conditions. Reports on Public Health and Medical Subjects, no. 32. Ministry of Health: London.
- Latha KS, Anitha S, Rao KS, Viswamitra MA. 2002. Molecular understanding of aluminium-induced topological changes in (CCG) 12 triplet repeats: relevance to neurological disorders. Biochemi. Biophys. Acta 1588: 56– 64.
- Lipworth L. 1995. Epidemiology of breast cancer. Eur. J. Cancer Prevent. 4: 7– 30.
- Miki Y, Swensen J, Shattuck-Eidens D, et al. 1994. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266: 66– 71.
- Miller WR. 1996. Estrogen and Breast Cancer. Chapman and Hall: London.
- Mirick DK, Davis S, Thomas DB. 2002. Antipersirant use and the risk of breast cancer. J. Natl. Cancer Insti. 94: 1578– 1580.
- Montemarano AD, Sau P, Johnson FB, James WD. 1997. Cutaneous granulomas caused by an aluminium-zirconium complex: an ingredient of antipersirants. J. Am. Acad. Dermatol. 37: 496– 498.
- Mulay IL, Roy R, Knox BE, Suhr NH, Delaney WE. 1971. Trace-metal analysis of cancerous and non-cancerous human tissues. J. Natl. Cancer Inst. 47: 1– 13.
- Murrell WG, Vincent JM. 1950. The 4-hydroxybenzoic acid esters and related compounds. 4. The bacteriostatic action of 4-hydroxybenzoic acid n-alkyl esters. J. Soc. Chem. Ind. 69: 109– 113.
- Nesaretnam K, Darbre P. 1997. 3,5,3′,5′-Tetrachlorobiphenyl is a weak oestrogen agonist in vitro and in vivo. J. Steroid Biochem. Mol. Biol. 62: 409– 418.
- Nesaretnam K, Corcoran D, Dils RR, Darbre P. 1996. 3,4,3′,4′-Tetrachlorobiphenyl acts as an oestrogen in vitro and in vivo. Mol. Endocrinol. 10: 923– 936.
- Nesaretnam K, Hales E, Mohammed S, Krausz T, Darbre P. 1998. 3,4,3′,4′-Tetrachlorobiphenyl (TCB) can enhance DMBA-induced mammary carcinogenesis in rat. Eur. J. Cancer 34: 389– 393.
- Newman LS. 1998. Metals that cause sarcoidosis. Semin. Respir. Infect. 13: 212– 220.
- Nohrman BA. 1949. Cancer of the breast. Acta Radiol. Suppl. 77.
- Okubo T, Yokoyama Y, Kano K, Kano I. 2001. ER-dependent estrogenic activity of parabens assessed by proliferation of human breast cancer MCF7 cells and expression of ERα and PR. Food Chem. Toxicol. 39: 1225– 1232.
- Patterson SK, Helvie MA, Joynt LK, Roubidoux MA, Strawderman M. 1998. Mammographic appearance of breast cancer in African–American women. Acad. Radiol. 5: 2– 8.
- Pedersen KL, Pedersen SN, Christiansen LB, Korsgaard B, Bjerregaard P. 2000. The preservatives ethyl-, propyl-, and butylparaben are oestrogenic in an in vivo fish assay. Pharmacol. Toxicol. 86: 110– 113.
- Raju GC, Naraynsingh V. 1989. Breast cancer in West Indian women in Trinidad. Trop. Geogr. Med. 41: 257– 260.
- Rimsten A. 1976. Symptoms and signs in benign and malignant tumours of the breast. Upsala. J. Med. Sci. 81: 54– 60.
- Rizk SN, Assimacopoulos CA, Ryan JJ. 1994. Male breast cancer: three case reports and review of the literature. SDJ Med. 47: 343– 346.
- Routledge EJ, Parker J, Odum J, Ashby J, Sumpter JP. 1998. Some alkyl hydroxy benzoate preservatives (parabens) are estrogenic. Toxicol. Appl. Pharmacol. 153: 12– 19.
- Russo J, Russo IH. 1987. Biology of disease. Biological and molecular bases of mammary carcinogenesis. Lab. Invest. 57: 112– 137.
- Skelton HG, Smith KJ, Johnson FB, Cooper CR, Tyler WF, Lupton GP. 1993. Zirconium granuloma resulting from an aluminium zirconium complex: a previously unrecognized agent in the development of hypersensitivity granulomas. J. Am. Acad. Dermatol. 28: 874– 876.
- Smith D. 1999. Worldwide trends in DDT levels in human breast milk. Int. J. Epidemiol. 28: 179– 188.
- Smithers DW, Rigby-Jones P, Galton DAG, Payne PM. 1952. Cancer of the breast. Br. J. Radiol. Suppl. 4.
- Stebbing JF, Nash AG. 1995. Diagnosis and management of phyllodes tumour of the breast: experience of 33 cases at a specialist centre. Ann. R. Coll. Surg. Engl. 77: 181– 184.
- Stowe CM, Plaa GL. 1968. Extrarenal excretion of drugs and chemicals. Annu. Rev. Pharmacol. 8: 337– 356.
- Tokunaga M, Norman JE, Asano M, Tokuoka S, Ezaki H, Nishimori I, Tsuji Y. 1979. Malignant breast tumors among atomic bomb survivors, Hiroshima and Nagasaki, 1950–74. J. Natl. Cancer Inst. 62: 1347– 1359.
- Truscott BM. 1947. Carcinoma of the breast. Br. J. Cancer 1: 129.
- Ursin G, Bernstein L, Pike MC. 1994. Breast cancer. Cancer Surv. 19/20: 241– 264.
- Wooster R, Bignell G, Lancaster J, et al. 1995. Identification of the breast cancer susceptibility bene BRCA2. Nature 378: 789– 792.
- Zhang RY, Liu Y, Pang DW, Cai RX, Qi YP. 2002. Spectroscopic and voltammetric study on the binding of aluminium(III) to DNA. Anal. Sci. 18: 761– 766.
